Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood

A population-based cross-sectional study

Bibliographic Data

ID15377352
AuthorsKyla Hayford (0000-0002-9872-2313, Johns Hopkins University, corresponding author), Kyla T Hayford, Mohammed Shohel Shomik (International Centre for Diarrhoeal Disease Research), Hassan M Al‐Emran (0000-0003-1185-6720, Child Health Research Foundation), Hassan M Al-Emran, William J Moss (0000-0001-6579-3513, Johns Hopkins University), David Bishai (0000-0003-0714-9062, Johns Hopkins University), Orin S Levine (0000-0001-6756-5653, Johns Hopkins University)
Year2013
Volume13
Issue1
Pages1211-1211
Publication date2013-12-01
Open AccessYes
TypeARTICLE
VenueBMC Public Health (JOURNAL)
Journal identifiersISSN: 1471-2458 • E-ISSN: 1471-2458
PublisherBioMed Central (PUBLISHER • GB)
DOI10.1186/1471-2458-13-1211
PMID24359402
PMCIDPMC3890518
OpenAlexW2065982056
LanguageEN
References cited31

Measles IgG antibodies in OF was not a suitable immune marker for monitoring measles vaccination coverage in this setting. Because agreement between conventional MCV1 indicators was mediocre, immune marker surveillance with blood samples could be used to validate conventional MCV1 indicators and generate adjusted results that can be compared across indicators

Biostatistics · Cross-sectional study · Environmental health · Measles · Pathology · Population · Public health · Vaccination · Immune responses and vaccinations · Medicine · Vaccine Coverage and Hesitancy · Virology and Viral Diseases · Epidemiology · Immunology · Internal Medicine · Pediatrics

Tools

Open DOISci-HubOpen Access